ClinicalTrials.gov record
Completed Phase 1 Interventional Accepts healthy volunteers

Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease

ClinicalTrials.gov ID: NCT06546995

Public ClinicalTrials.gov record NCT06546995. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 12:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease

Study identification

NCT ID
NCT06546995
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Neumora Therapeutics, Inc.
Industry
Enrollment
96 participants

Conditions and interventions

Interventions

  • NMRA-323511 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
55 Years to 90 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 8, 2024
Primary completion
Nov 18, 2025
Completion
Nov 18, 2025
Last update posted
Nov 20, 2025

2024 – 2025

United States locations

U.S. sites
26
U.S. states
12
U.S. cities
24
Facility City State ZIP Site status
Neumora Investigator Site Chandler Arizona 85286
Neumora Investigator Site Tempe Arizona 85283
Neumora Investigator Site Costa Mesa California 92626
Neumora Investigator Site Lomita California 90717
Neumora Investigator Site Walnut Creek California 94596
Neumora Investigator Site Bradenton Florida 34205
Neumora Investigator Site Greenacres City Florida 33467
Neumora Investigator Site Hallandale Florida 33009
Neumora Investigator Site Hialeah Florida 33016
Neumora Investigator Site Miami Florida 33126
Neumora Investigator Site Miami Florida 33137
Neumora Investigator Site Miami Florida 33155
Neumora Investigator Site Miami Springs Florida 33166
Neumora Investigator Site Orlando Florida 32807
Neumora Investigator Site Pembroke Pines Florida 33024
Neumora Investigator Site Port Orange Florida 32127
Neumora Investigator Site Atlanta Georgia 30318
Neumora Investigator Site Honolulu Hawaii 96817
Neumora Investigator Site Boise Idaho 83704
Neumora Investigator Site Belmont Massachusetts 02478
Neumora Investigator Site Troy Michigan 48085
Neumora Investigator Site Toms River New Jersey 08755
Neumora Investigator Site Brooklyn New York 11229
Neumora Investigator Site East Syracuse New York 13057
Neumora Investigator Site Charlotte North Carolina 28204
Neumora Investigator Site Mesquite Texas 75149

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06546995, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 20, 2025 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06546995 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →